On May 27, 2025, bioAffinity Technologies, Inc. was notified by Nasdaq that it does not meet the required stockholders' equity minimum of $2,500,000, with its reported equity at $1,439,404. The company has 45 days to submit a plan to regain compliance; failure to do so could lead to delisting.